<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated 49 acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (ARLs) for Epstein-Barr virus (EBV) by Southern blotting and in situ hybridization and, in positive cases, used cryostat immunohistology to compare EBV-latent gene expression (EBV encoded small <z:chebi fb="40" ids="33697">RNA</z:chebi>-1 [EBER-1], EBV nuclear antigen-2 [EBNA-2], latent membrane protein-1 [LMP-1] and host cell immunophenotype (CD11a, CD18, CD54, CD58, CD21, CD23, CD30, CD39, CDw70, immunoglobulin) patterns with those reported in other <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infections</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>EBV+ immunoblast-rich/large cell ARLs (n = 22) showed three patterns of latency: broad (EBER+EBNA-2+/LMP-1+; n = 9), reminiscent of a lymphoblastoid cell line phenotype; restricted (EBER+/EBNA-2-/LMP-1-; n = 6), similar to endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; and intermediate (EBER+/EBNA-2-/LMP-1+; n = 7), a pattern rarely described in vitro but seen in certain <z:e sem="disease" ids="C1333432" disease_type="Neoplastic Process" abbrv="">EBV-related malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>EBNA-2 expression was associated with extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>EBV+ Burkitt-type ARLs (n = 11) usually showed the restricted latency pattern (n = 8), but some expressed the intermediate form (n = 3) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Adhesion</z:e> (CD54, CD58) and activation (CD30, CD39, CDw70) molecule expression varied with <z:mp ids='MP_0000002'>morphology</z:mp> (immunoblast-rich/large cell versus Burkitt-type), but was not independently correlated with EBV-positivity </plain></SENT>
<SENT sid="5" pm="."><plain>CD30 and LMP-1 expression were associated </plain></SENT>
<SENT sid="6" pm="."><plain>ARLs show <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> regarding both the presence of EBV and latency pattern </plain></SENT>
<SENT sid="7" pm="."><plain>Comparison of these phenotypically distinct <z:hpo ids='HP_0002665'>lymphoma</z:hpo> groups with known forms of <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> provides clues to their possible pathogenesis </plain></SENT>
</text></document>